Polypharmacology is an enduring and nearly universal property of kinase inhibitors
Caitlin E. Mills, Clemens B. Hug, Karuna Anna Sajeevan, Nicholas Clark, Chiara Victor, Mirra Chung, Sameer Rawat, Hope D’Erasmo, Mariana Pereira Moraes, Bree B. Aldridge, Mark W. Albers, Ratul Chowdhury, Benjamin M. Gyori, Peter Karl Sorger
This paper shows that kinase inhibitors commonly target multiple kinases, independent of approval status, and highlights the need for better understanding of their polypharmacology.
bioRxiv · Apr 30, 2026 · PreprintPharmacology & Toxicology